• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pharmacological Augmentation of Psychosocial and Remediation Training Efforts in Schizophrenia.精神分裂症心理社会及康复训练的药物增强疗法
Front Psychiatry. 2017 Sep 25;8:177. doi: 10.3389/fpsyt.2017.00177. eCollection 2017.
2
Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder.胍法辛增强计算机认知矫正治疗和社交技能训练联合干预精神分裂型人格障碍。
Am J Psychiatry. 2019 Apr 1;176(4):307-314. doi: 10.1176/appi.ajp.2018.18030349. Epub 2019 Jan 18.
3
Neural changes following cognitive remediation therapy for schizophrenia.精神分裂症认知矫正治疗后的神经变化。
Psychiatry Clin Neurosci. 2019 Nov;73(11):676-684. doi: 10.1111/pcn.12912. Epub 2019 Aug 4.
4
Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development.奖励学习作为精神分裂症认知矫正药物增强的潜在靶点:临床前开发的路线图。
Front Neurosci. 2013 Jun 18;7:103. doi: 10.3389/fnins.2013.00103. eCollection 2013.
5
The potential of nicotinic enhancement of cognitive remediation training in schizophrenia.烟碱增强认知矫正治疗对精神分裂症的潜在作用。
Neuropharmacology. 2013 Jan;64:185-90. doi: 10.1016/j.neuropharm.2012.05.050. Epub 2012 Jun 13.
6
Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial.认知矫正治疗对早发性精神分裂症青少年患者的效果:一项随机对照试验。
J Am Acad Child Adolesc Psychiatry. 2014 Aug;53(8):859-68. doi: 10.1016/j.jaac.2014.05.012. Epub 2014 Jun 21.
7
Cognitive remediation therapy for schizophrenia: what is it and does it work?
Ir J Psychol Med. 2011 Dec;28(4):217-221. doi: 10.1017/S0790966700011691.
8
Does social cognition training augment response to computer-assisted cognitive remediation for schizophrenia?社会认知训练是否能增强精神分裂症计算机辅助认知矫正的反应?
Schizophr Res. 2018 Nov;201:180-186. doi: 10.1016/j.schres.2018.06.012. Epub 2018 Jun 14.
9
Cognitive remediation therapy for eating disorders.认知矫正治疗进食障碍。
Curr Opin Psychiatry. 2015 Nov;28(6):468-72. doi: 10.1097/YCO.0000000000000192.
10
Lessons learnt? The importance of metacognition and its implications for Cognitive Remediation in schizophrenia.学到了什么?元认知的重要性及其对精神分裂症认知康复的启示。
Front Psychol. 2015 Sep 1;6:1259. doi: 10.3389/fpsyg.2015.01259. eCollection 2015.

引用本文的文献

1
Memory Function in Euthymic Patients with Bipolar I Disorder: A Cross-Sectional Study of Clinical and Demographic Correlates.双相I型障碍心境正常患者的记忆功能:临床及人口统计学相关因素的横断面研究
Med J Islam Repub Iran. 2025 Mar 6;39:36. doi: 10.47176/mjiri.39.36. eCollection 2025.
2
Efficacy and safety of iclepertin (BI 425809) with adjunctive computerized cognitive training in patients with schizophrenia.艾考必利(BI 425809)联合计算机化认知训练用于精神分裂症患者的疗效与安全性
Schizophr Res Cogn. 2024 Dec 14;40:100340. doi: 10.1016/j.scog.2024.100340. eCollection 2025 Jun.
3
Examining the impact of a group treatment using cognitive and social cognition remediation for young offenders: The justice health NSW school-link advantage pilot study.考察认知与社会认知矫正团体治疗对青少年罪犯的影响:新南威尔士州司法健康学校联系优势试点研究。
Early Interv Psychiatry. 2025 Jan;19(1):e13560. doi: 10.1111/eip.13560. Epub 2024 May 19.
4
Valuable interaction with cognitive remediation and optimal antipsychotics for recovery in schizophrenia (VICTORY-S): study protocol for an interventional, open-label, randomized comparison of combined treatment with cognitive remediation and lurasidone or paliperidone.精神分裂症康复中认知康复与最佳抗精神病药物的有效相互作用(VICTORY-S):认知康复与鲁拉西酮或帕利哌酮联合治疗的干预性、开放标签、随机对照研究方案
Front Psychiatry. 2024 Feb 6;14:1331356. doi: 10.3389/fpsyt.2023.1331356. eCollection 2023.
5
The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression.二甲双胍对精神分裂症患者认知及其他症状维度和抗精神病药物所致体重增加的潜在影响:一项系统评价、荟萃分析和荟萃回归分析
Front Psychiatry. 2023 Jul 12;14:1215807. doi: 10.3389/fpsyt.2023.1215807. eCollection 2023.
6
Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system.跨诊断认知功能的决定因素:毒蕈碱型乙酰胆碱受体作为一个模型系统。
Transl Psychiatry. 2023 Mar 27;13(1):100. doi: 10.1038/s41398-023-02400-x.
7
A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial.一种新的、简短的、完全自动化的干预措施,可以延长单次氯胺酮输注的抗抑郁效果:一项随机临床试验。
Am J Psychiatry. 2022 Dec 1;179(12):959-968. doi: 10.1176/appi.ajp.20220216. Epub 2022 Sep 21.
8
Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art.精神分裂症中的认知功能障碍:关于当前技术水平的专家小组论文
Schizophr Res Cogn. 2022 Mar 22;29:100249. doi: 10.1016/j.scog.2022.100249. eCollection 2022 Sep.
9
Acceptability of cognitive remediation for schizophrenia: a systematic review and meta-analysis of randomized controlled trials.认知矫正治疗精神分裂症的可接受性:一项随机对照试验的系统评价和荟萃分析。
Psychol Med. 2023 Jun;53(8):3661-3671. doi: 10.1017/S0033291722000319. Epub 2022 Mar 8.
10
Advances in Cognitive Remediation Training in Schizophrenia: A Review.精神分裂症认知康复训练的进展:综述
Brain Sci. 2022 Jan 18;12(2):129. doi: 10.3390/brainsci12020129.

本文引用的文献

1
The feasibility of implementing cognitive remediation for work in community based psychiatric rehabilitation programs.在社区精神康复项目中开展认知康复工作的可行性。
Psychiatr Rehabil J. 2017 Mar;40(1):79-86. doi: 10.1037/prj0000257.
2
Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients.苯丙胺增强成年精神分裂症患者听觉辨别训练的效果。
Schizophr Bull. 2017 Jul 1;43(4):872-880. doi: 10.1093/schbul/sbw148.
3
Social cognitive interventions for people with schizophrenia: A systematic review.社交认知干预对精神分裂症患者的影响:系统综述。
Asian J Psychiatr. 2018 Jun;35:115-131. doi: 10.1016/j.ajp.2016.06.013. Epub 2016 Sep 23.
4
Measuring and Facilitating Client Engagement with Financial Incentives: Implications for Improving Clinical Outcomes in a Mental Health Setting.衡量并促进客户对经济激励措施的参与度:对改善心理健康环境下临床结果的启示。
Community Ment Health J. 2017 Jul;53(5):501-509. doi: 10.1007/s10597-016-0053-z. Epub 2016 Sep 26.
5
Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: a 3-year prospective cohort study.精神分裂症患者的抗胆碱能负担及从心理社会治疗项目中获益的能力:一项为期3年的前瞻性队列研究
Psychol Med. 2016 Nov;46(15):3199-3211. doi: 10.1017/S0033291716002154. Epub 2016 Aug 31.
6
The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study.α7烟碱激动剂ABT-126治疗非吸烟者精神分裂症相关认知障碍:一项随机对照2b期研究的结果
Neuropsychopharmacology. 2016 Nov;41(12):2893-2902. doi: 10.1038/npp.2016.101. Epub 2016 Jun 20.
7
The Therapeutic Role of d-Cycloserine in Schizophrenia.D-环丝氨酸在精神分裂症中的治疗作用。
Adv Pharmacol. 2016;76:39-66. doi: 10.1016/bs.apha.2016.02.001. Epub 2016 Mar 11.
8
Insight and subjective measures of quality of life in chronic schizophrenia.慢性精神分裂症患者生活质量的洞察与主观测量
Schizophr Res Cogn. 2015 Sep 1;2(3):127-132. doi: 10.1016/j.scog.2015.05.002. Epub 2015 Jun 9.
9
Intensive Auditory Cognitive Training Improves Verbal Memory in Adolescents and Young Adults at Clinical High Risk for Psychosis.强化听觉认知训练可改善临床高风险精神病性青少年和青年的言语记忆。
Schizophr Bull. 2016 Jul;42 Suppl 1(Suppl 1):S118-26. doi: 10.1093/schbul/sbw009. Epub 2016 Feb 22.
10
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.伐尼克兰对精神分裂症患者吸烟、认知及精神症状的影响:一项双盲随机试验
PLoS One. 2016 Jan 5;11(1):e0143490. doi: 10.1371/journal.pone.0143490. eCollection 2016.

精神分裂症心理社会及康复训练的药物增强疗法

Pharmacological Augmentation of Psychosocial and Remediation Training Efforts in Schizophrenia.

作者信息

Harvey Philip D, Sand Michael

机构信息

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States.

Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, United States.

出版信息

Front Psychiatry. 2017 Sep 25;8:177. doi: 10.3389/fpsyt.2017.00177. eCollection 2017.

DOI:10.3389/fpsyt.2017.00177
PMID:28993740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5622160/
Abstract

Pharmacological approaches to cognitive enhancement have received considerable attention but have not had considerable success in improving their cognitive and functional targets. Other intervention strategies, such as cognitive remediation therapy (CRT), have been shown to enhance cognitive performance but have not been found to improve functional outcomes without additional psychosocial interventions. Recently, several studies have attempted to enhance the effects of CRT by adding pharmacological interventions to the CRT treatments. In addition, as CRT has been shown to synergistically improve the effects of psychosocial interventions, the combination of pharmacological therapies aimed at cognition and psychosocial interventions may itself provide a promising strategy for improving functional outcomes. This review and commentary examines the current state of interventions combining CRT and psychosocial treatments with pharmacological augmentation. Our focus is on the specific level of effect of the pharmacological intervention, which could be enhancing motivation, training efficiency, or the consolidation of therapeutic gains. Different pharmacological strategies (e.g., stimulants, plasticity-inducing agents, or attentional or alertness enhancers) may have the potential to lead to different types of gains when combined with CRT or psychosocial interventions. The relative potential of these different mechanisms for immediate and durable effects is considered.

摘要

认知增强的药理学方法已受到广泛关注,但在改善认知和功能目标方面尚未取得显著成功。其他干预策略,如认知康复治疗(CRT),已被证明可提高认知表现,但如果没有额外的心理社会干预,尚未发现能改善功能结局。最近,一些研究试图通过在CRT治疗中添加药理学干预来增强CRT的效果。此外,由于CRT已被证明能协同改善心理社会干预的效果,针对认知的药物治疗与心理社会干预相结合本身可能为改善功能结局提供一种有前景的策略。这篇综述和评论探讨了将CRT、心理社会治疗与药理学增强相结合的干预措施的现状。我们关注的是药理学干预的具体作用水平,其可能是增强动机、训练效率或巩固治疗效果。不同的药理学策略(如兴奋剂、可塑性诱导剂或注意力或警觉性增强剂)与CRT或心理社会干预相结合时,可能有潜力带来不同类型的效果。本文考虑了这些不同机制产生即时和持久效果的相对潜力。